The Impact Bridge (@theimpactbridge) header
The Impact Bridge (@theimpactbridge) profile picture

Translating China’s burgeoning healthcare sector into global opportunities.

Beijing, China
Joined April 2009
Photo by The Impact Bridge (@theimpactbridge)Photo by The Impact Bridge (@theimpactbridge)Photo by The Impact Bridge (@theimpactbridge)Photo by The Impact Bridge (@theimpactbridge)Photo by The Impact Bridge (@theimpactbridge)Photo by The Impact Bridge (@theimpactbridge)Photo by The Impact Bridge (@theimpactbridge)Photo by The Impact Bridge (@theimpactbridge)Photo by The Impact Bridge (@theimpactbridge)Photo by The Impact Bridge (@theimpactbridge)
Last week in #China #vaccine news (Dec.23-Dec.29) ➡️China’s CDE issued two new vaccine-related guidelines: “Guidelines for Statistical Principles in Vaccine Clinical Trials” and “Guidelines for Pharmaceutical Research and Evaluation of Conjugated Polysaccharide Vaccines”.
1
1
120
- Newish Technology applied for clinical trials for NWRD09, a new #HPV therapeutic vaccine against HPV16-related tumors. - @cansinobio_inc reported its recombinant shingles vaccine has completed all on-site work for Phase I trials conducted in Canada and now analysing data.
1
134
Last week in #China #vaccine news (Dec.16-Dec.22) ➡️China’s State Council appointed Xia Gang as the new Vice Administrator of China's National Disease Control and Prevention Administration, replacing the retiring Chang Jile.
1
2
104
➡️Rhegen Bio applied for clinical trials for its freeze-dried bivalent RSV mRNA vaccine. ➡️LVRNA101, an mRNA vaccine against HSV-2 jointly developed by LiveRNA Therapeutics Inc. and BCHTPharm, has been approved for clinical trials.
165
Last week in #China #vaccine news (Dec.9-Dec.15) Multiple updates on clinical trials: ➡️Suzhou Abogen Biosciences submitted application for clinical trials for its #RSV #mRNA vaccine, marking the third such candidate in China after submissions by NanoRibo and @sinovac.
1
1
124
➡️Guangzhou Patronus Biotech has obtained approval to conduct clinical trials in China for its recombinant RSV vaccine, LYB005, which previously began Phase I trials in Australia in July. ➡️TheraVac launched Phase I trials of its recombinant #shingles vaccine (CHO cell).
1
81
➡️The Beijing Institute of Biological Products of @ChinaSinopharm received IND approval from China’s CDE for its #Mpox vaccine. ➡️@WantaiBio announced the successful completion of Phase I clinical trials for its hepatitis E vaccine in the US.
1
107
Last week in #China #vaccine news (Dec.2-Dec.8) ➡️Updates with mRNA vaccines - @Sinovac applied for clinical trials for its freeze-dried #RSV mRNA vaccine. - Youcare Pharmaceutical received approval from US FDA to conduct trials for its #shingles mRNA vaccine YKYY026.
1
1
1
132
➡️1,000 doses of bivalent #HPV vaccine Cecolin were donated to Nepal as part of the “HPV Vaccine and Cervical Cancer Screening Technology Demonstration Project” funded by China’s Ministry of Science and Technology.
1
70
➡️@Sinovac has established a new subsidiary, Sinovac (Chengdu) Biotech, in Southwestern China. The subsidiary will focus on advancing its serum-free, Vero cell-based freeze-dried #rabies vaccine, which has completed Phase III trials.
1
69